絞り込み

16767

広告

Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.

著者 Morency D , Dumitra S , Parvez E , Martel K , Basik M , Robidoux A , Poirier B , Holloway CMB , Gaboury L , Sideris L , Meterissian S , Boileau JF
Ann Surg Oncol.2019 Oct 11 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (4view , 0users)

Full Text Sources

The sentinel node biopsy following neoadjuvant chemotherapy (SN FNAC) study has shown that in node-positive (N+) breast cancer, sentinel node biopsy (SNB) can be performed following neoadjuvant chemotherapy (NAC), with a low false negative rate (FNR = 8.4%). A secondary endpoint of the SN FNAC study was to determine whether axillary ultrasound (AxUS) could predict axillary pathological complete response (ypN0) and increase the accuracy of SNB.
PMID: 31605348 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード